Clinical trial
AI-Guided Proteomic Discovery and Multi-Cohort Validation of a Circulative Protein Signature to Differentiate Bacterial and Viral Infections in Acute Febrile Illness
NCT07205575 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AI-Guided Proteomic Discovery and Multi-Cohort Validation of a Circulative Protein Signature to Differentiate Bacterial and Viral Infections in Acute Febrile Illness
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- November 30, 2024
- Enrollment
- 394 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute febrile illness, bacterial infections, sepsis, viral infections